Göran Landberg

13.0k total citations
211 papers, 10.2k citations indexed

About

Göran Landberg is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Göran Landberg has authored 211 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 121 papers in Oncology, 100 papers in Molecular Biology and 62 papers in Cancer Research. Recurrent topics in Göran Landberg's work include Cancer-related Molecular Pathways (56 papers), Cancer Cells and Metastasis (37 papers) and Estrogen and related hormone effects (28 papers). Göran Landberg is often cited by papers focused on Cancer-related Molecular Pathways (56 papers), Cancer Cells and Metastasis (37 papers) and Estrogen and related hormone effects (28 papers). Göran Landberg collaborates with scholars based in Sweden, United Kingdom and United States. Göran Landberg's co-authors include Karin Jirström, Göran Roos, Lisa Rydén, Stefan O. Emdin, Katja Lundgren, Bo Nordenskjöld, Caroline Holm, Niels Hilmer Nielsen, Olle Stål and Sven Påhlman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Göran Landberg

208 papers receiving 10.0k citations

Peers

Countries citing papers authored by Göran Landberg

Since Specialization

Citations

This map shows the geographic impact of Göran Landberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Göran Landberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Göran Landberg more than expected).

Fields of papers citing papers by Göran Landberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Göran Landberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Göran Landberg. The network helps show where Göran Landberg may publish in the future.

Co-authorship network of co-authors of Göran Landberg

This figure shows the co-authorship network connecting the top 25 collaborators of Göran Landberg. A scholar is included among the top collaborators of Göran Landberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Göran Landberg. Göran Landberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Deciphering the role of FUS::DDIT3 expression and tumor microenvironment in myxoid liposarcoma development 2024 ·Journal of Translational Medicine ·(unknown), Emma Jonasson, Lisa Andersson, Stefan Filges, (unknown), (unknown), Soheila Dolatabadi, (unknown), Ola Myklebost, Joakim Håkansson, Henrik Fagman, Göran Landberg, Pierre Åman, Anders Ståhlberg	1
2	Breast cancer stromal clotting activation (Tissue Factor and thrombin): A pre‐invasive phenomena that is prognostic in invasion 2020 ·Cancer Medicine ·(unknown), Nigel Bundred, Göran Landberg, Susan Pritchard, (unknown), Sarah Leigh Nicholson, (unknown), (unknown), (unknown), Cliona Kirwan	23
3	Cellular organization and molecular differentiation model of breast cancer-associated fibroblasts 2017 ·Molecular Cancer ·Susann Busch, Daniel Andersson, (unknown), Claire Walsh, Anders Ståhlberg, Göran Landberg	46
4	An Endothelial Gene Signature Score Predicts Poor Outcome in Patients with Endocrine-Treated, Low Genomic Grade Breast Tumors 2016 ·Clinical Cancer Research ·Nicholas P. Tobin, Kristian Wennmalm, Linda S. Lindström, Theodoros Foukakis, Liqun He, Guillem Genové, Arne Östman, Göran Landberg, Christer Betsholtz, Jonas Bergh	7
5	Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance 2015 ·Cancer Research ·Susann Busch, Andrew H. Sims, Olle Stål, Mårten Fernö, Göran Landberg	22
6	Properties of targeted preamplification in DNA and cDNA quantification 2015 ·Expert Review of Molecular Diagnostics ·Daniel Andersson, Nina Akrap, Dávid Švec, Tony E. Godfrey, Mikael Kubista, Göran Landberg, Anders Ståhlberg	36
7	The Notch Pathway Inhibits TGFβ Signaling in Breast Cancer through HEYL-Mediated Crosstalk 2014 ·Cancer Research ·Liangfeng Han, Adam Diehl, Nguyen K. Nguyen, Preethi Korangath, Wei Wen Teo, Soonweng Cho, Scott L. Kominsky, David L. Huso, Lionel Feigenbaum, Alan Rein, Pedram Argani, Göran Landberg, Manfred Gessler, Saraswati Sukumar	27
8	Low PIP4K2B Expression in Human Breast Tumors Correlates with Reduced Patient Survival: A Role for PIP4K2B in the Regulation of E-Cadherin Expression 2013 ·Cancer Research ·Willem‐Jan Keune, Andrew H. Sims, D. I. Jones, Yvette Bultsma, James T. Lynch, Karin Jirström, Göran Landberg, Nullin Divecha	40
9	Contrasting Hypoxic Effects on Breast Cancer Stem Cell Hierarchy Is Dependent on ER-α Status 2012 ·Cancer Research ·Hannah Harrison, Lynsey Rogerson, (unknown), Keith Brennan, Robert B. Clarke, Göran Landberg	50
10	Stromal Expression of β-Arrestin-1 Predicts Clinical Outcome and Tamoxifen Response in Breast Cancer 2011 ·Journal of Molecular Diagnostics ·Katja Lundgren, Nicholas P. Tobin, Sophie Lehn, Olle Stål, Lisa Rydén, Karin Jirström, Göran Landberg	23
11	Food Sources of Fat and Sex Hormone Receptor Status of Invasive Breast Tumors in Women of the Malmö Diet and Cancer Cohort 2011 ·Nutrition and Cancer ·Elisabet Wirfält, Cairu Li, Jonas Manjer, Ulrika Ericson, Emily Sonestedt, Signe Borgquist, Göran Landberg, Håkan Olsson, Bo Gullberg	14
12	Cyclooxygenase-2 Inhibition Does Not Improve the Reduction in Ductal Carcinoma In situ Proliferation with Aromatase Inhibitor Therapy: Results of the ERISAC Randomized Placebo-Controlled Trial 2010 ·Clinical Cancer Research ·Nigel Bundred, Angela Cramer, Julie Morris, Lorna Renshaw, Kwok‐Leung Cheung, (unknown), (unknown), Oliver Young, Göran Landberg, (unknown), (unknown), A.D. Baildam, Lester Barr, J. Michael Dixon	33
13	Extranuclear Coactivator Signaling Confers Insensitivity to Tamoxifen 2009 ·Clinical Cancer Research ·Rakesh Kumar, Hao Zhang, Caroline Holm, Ratna K. Vadlamudi, Göran Landberg, Suresh K. Rayala	35
14	Erythropoietin Receptor Expression and Correlation to Tamoxifen Response and Prognosis in Breast Cancer 2009 ·Clinical Cancer Research ·Anna-Maria Larsson, Karin Jirström, Erik Fredlund, (unknown), Lisa Rydén, Göran Landberg, Sven Påhlman	21
15	Altered Cytoplasmic-to-Nuclear Ratio of Survivin Is a Prognostic Indicator in Breast Cancer 2008 ·Clinical Cancer Research ·Donal J. Brennan, Elton Rexhepaj, Sallyann L. O’Brien, Elaine McSherry, Darran P. O’Connor, Ailís Fagan, Aedín C. Culhane, Desmond G. Higgins, Karin Jirström, Robert C. Millikan, Göran Landberg, Michael J. Duffy, Stephen M. Hewitt, William M. Gallagher	71
16	Hypoxia-Inducible Factor-2α Correlates to Distant Recurrence and Poor Outcome in Invasive Breast Cancer 2008 ·Cancer Research ·(unknown), Anna-Maria Larsson, Linda Holmquist Mengelbier, Esther Bridges, Erik Fredlund, Signe Borgquist, Göran Landberg, Sven Påhlman, Karin Jirström	111
17	CA IX is an Independent Prognostic Marker in Premenopausal Breast Cancer Patients with One to Three Positive Lymph Nodes and a Putative Marker of Radiation Resistance 2006 ·Clinical Cancer Research ·Donal J. Brennan, Karin Jirström, Åsa Kronblad, Robert C. Millikan, Göran Landberg, Michael J. Duffy, Lisa Rydén, William M. Gallagher, Sallyann L. O’Brien	107
18	Carbonic anhydrase IX is a new independent prognostic marker in pre-menopausal breast cancer patients with 1 to 3 positive lymph nodes 2006 ·Cancer Research ·Donal J. Brennan, Åsa Kronblad, Karin Jirström, Göran Landberg, Michael J. Duffy, William M. Gallagher, (unknown)	3
19	C-erbB2, p27 and G1/S aberrations in human primary breast cancer. 2003 ·PubMed ·Martin Lodén, (unknown), Niels Hilmer Nielsen, Stefan O. Emdin, Göran Landberg	8
20	Autoantibody to DNA topoisomerase II in primary liver cancer 1995 ·PubMed ·Haruhiko Imai, Kunimaro Furuta, Göran Landberg, Kendo Kiyosawa, (unknown), (unknown)	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact